Observational Safety Study of Adjuvanted Swine Origin A (H1N1) Pandemic Subunit Egg Derived Vaccine

CompletedOBSERVATIONAL
Enrollment

7,284

Participants

Timeline

Start Date

December 31, 2009

Primary Completion Date

March 31, 2011

Study Completion Date

March 31, 2011

Conditions
Pandemic Influenza A (H1N1)A New Flu Virus of Swine Origin
Interventions
OTHER

Non-intervention observational study

Non-intervention observational study

Trial Locations (14)

Unknown

Hospital Garrahan, Combate de Los Pozos 1881

"Hospital de Ninos Dr. Ricardo Gutierrez", Gallo 1330

Hospital Nuestra Señora de la Misericordia, Belgrano 1500

Hospital Pediatrico del Niño Jesus, Castro Barros 650 - San Martín

Sanatorio Mayo Privado S.A., Humberto Primo 520

"Hospital Pediatrico Dr. Humberto Notti", Bandera de Los Andes 2603 Villa Nueva

7691BV

Huisartsenpraktijk Bergentheim, Kanaalweg West 61

4819HH

Huisartsenpraktijk Bredero, Brederostraat 2/A

7741GB

Saxenburg Groep, Zorgcentrum Aleida Kramer, M.v.d. Thijnensingel 1

7822EL

Huisartsenpraktijk Dennenlaan, Dennenlaan 56

8281CK

Huisartsenpraktijk de Steenpoort, Prinses Julianastraat 25

7783AL

Huisartsenpraktijk Gramsbergen, Voorstraat 3

7861AM

Huisartsenpraktijk Oosterhesselen, Edveensweg 13

8011JW

Isala Klinieken Zwolle, Groot Wezenland 20

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Novartis Vaccines

INDUSTRY

NCT01040741 - Observational Safety Study of Adjuvanted Swine Origin A (H1N1) Pandemic Subunit Egg Derived Vaccine | Biotech Hunter | Biotech Hunter